Protocol Ledger

NCT06748222 · Phase III · RECRUITING

E-Mindfulness Approaches for Living After Breast Cancer

Interventional Phase III clinical trial protocol NCT06748222 sponsored by NRG Oncology in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2025-06-27 Enrollment: 402 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT06748222
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)402 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06748222
Protocol FieldVerified Registry Value
NCT IdentifierNCT06748222
Consolidated Lead SponsorNRG Oncology
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment402 participants (ESTIMATED)
Registered Start Date2025-06-27
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI